By bridging computational innovation with clinical application, our work not only underscores the pivotal role of CDKN2A in cancer prognosis but also marks a step forward in the quest for personalized cancer therapies, aligning with the broader objectives of precision medicine. Here, CDKN2A is linked to cancer.